ahlam1399
09-07-2016, 04:30 PM
UPDATE 1-Retrophin kidney drug succeeds in mid-stage study, shares jump
Sept 7 (Reuters) - Retrophin Inc said its drug totreat a rare kidney disorder met the main goal of a mid-stagestudy, sending the company's shares up nearly 35 percent inpremarket trading on...http://feeds.feedburner.com/~ff/reuters/hotStocksNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=Cp851OJo5Qs:MSQVEKxFlZc:yIl2AUoC8z A) http://feeds.feedburner.com/~ff/reuters/hotStocksNews?i=Cp851OJo5Qs:MSQVEKxFlZc:F7zBnMyn0L o (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=Cp851OJo5Qs:MSQVEKxFlZc:F7zBnMyn0L o) http://feeds.feedburner.com/~ff/reuters/hotStocksNews?i=Cp851OJo5Qs:MSQVEKxFlZc:V_sGLiPBpW U (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=Cp851OJo5Qs:MSQVEKxFlZc:V_sGLiPBpW U)
http://feeds.feedburner.com/~r/reuters/hotStocksNews/~4/Cp851OJo5Qs
Sept 7 (Reuters) - Retrophin Inc said its drug totreat a rare kidney disorder met the main goal of a mid-stagestudy, sending the company's shares up nearly 35 percent inpremarket trading on...http://feeds.feedburner.com/~ff/reuters/hotStocksNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=Cp851OJo5Qs:MSQVEKxFlZc:yIl2AUoC8z A) http://feeds.feedburner.com/~ff/reuters/hotStocksNews?i=Cp851OJo5Qs:MSQVEKxFlZc:F7zBnMyn0L o (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=Cp851OJo5Qs:MSQVEKxFlZc:F7zBnMyn0L o) http://feeds.feedburner.com/~ff/reuters/hotStocksNews?i=Cp851OJo5Qs:MSQVEKxFlZc:V_sGLiPBpW U (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=Cp851OJo5Qs:MSQVEKxFlZc:V_sGLiPBpW U)
http://feeds.feedburner.com/~r/reuters/hotStocksNews/~4/Cp851OJo5Qs